Soho Flordis International (SFI) is a global natural medicine company committed to identifying and developing leading natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

SFI is focused on bringing its products to market through healthcare professionals with the endorsement of world class opinion leaders.


SFI is committed to ensuring that people globally have access to quality, innovative evidence based natural medicines. Therefore it is our aim that the safety and efficacy claims for our products are supported by specific clinical evidence. This higher standard enables the selection of safe, appropriate and effective treatments.
View our brands here.


SFI is building an international community of leading herbal and medical companies, experts, scientists and researchers.
View our partners here.


We are committed to further developing the evidence for our products.
View our research programs here.

latest news

Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen™ brand portfolio from Vifor Pharma

Friday, October 23, 2015 - 10:19
Soho Flordis International (SFI), through its Swiss subsidiary company Ginsana SA, will acquire leading UK manufacturer and supplier of traditional herbal treatments Potters, from Vifor Pharma, a company of the Galenica Group.

Not all studies are created equal, just like natural medicines

Thursday, August 6, 2015 - 16:44
Sydney, Australia: Following the recent Medical Journal of Australia publication of a Monash University research paper reviewing ‘Use of complementary and alternative medicines (CAMs) for menopausal women’, Flordis Pty Ltd, a leading marketer of clinically proven natural medicines to healthcare professionals, would like to address a number of misleading statements made regarding the use of CAMs to treat symptoms of menopause.

Gincosan® launched in Indonesia

Monday, June 15, 2015 - 09:52
Soho Flordis International (SFI) is proud to announce the launch of Gincosan® in Indonesia in June 2015, together with its local partner SOHO Global Health. SOHO is one of Indonesia’s leading healthcare companies. Gincosan® is a unique, synergistic combination of GK501® Ginkgo biloba and G115® Panax ginseng to improve cognitive health.

Nigel Pollard of Soho Flordis International featured in CEO Magazine

Thursday, May 7, 2015 - 15:58
St Leonards, NSW, Australia: May 07, 2015 – Soho Flordis International is proud to announce that an interview with CEO, Nigel Pollard has featured in the May 2015 edition of CEO Magazine. Soho Flordis International has brought together established subsidiaries that have been in operation for up to 73 years, including Flordis Pty Ltd, Ginsana SA and ProThera Inc.